These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

667 related items for PubMed ID: 15996321

  • 1. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
    Zhao XW, Jiang B, Han CZ, Jing JX.
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321
    [Abstract] [Full Text] [Related]

  • 2. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P.
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [Abstract] [Full Text] [Related]

  • 3. Tumor markers in staging and prognosis of colorectal carcinoma.
    Levy M, Visokai V, Lipska L, Topolcan O.
    Neoplasma; 2008 Mar; 55(2):138-42. PubMed ID: 18237252
    [Abstract] [Full Text] [Related]

  • 4. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C, Chen LQ, Yang GL, Li Y.
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [Abstract] [Full Text] [Related]

  • 5. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.
    Cancer Res; 2001 Mar 15; 61(6):2523-32. PubMed ID: 11289125
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X, Lu XH, Xu T, Qian JM, Zhao P, Guo XZ, Yang XO, Jiang WJ.
    Chin J Dig Dis; 2006 Mar 15; 7(3):170-4. PubMed ID: 16808798
    [Abstract] [Full Text] [Related]

  • 7. [Significance of CEA and CA242 in the diagnosis of colorectal carcinoma].
    Wu J, Yu H, Shao Y.
    Zhonghua Zhong Liu Za Zhi; 1995 Nov 15; 17(6):438-40. PubMed ID: 8697997
    [Abstract] [Full Text] [Related]

  • 8. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R.
    Anticancer Res; 2000 Nov 15; 20(6D):5195-8. PubMed ID: 11326694
    [Abstract] [Full Text] [Related]

  • 9. The use of tumor markers as predictors of prognosis in gastric cancer.
    Mihmanli M, Dilege E, Demir U, Coskun H, Eroglu T, Uysalol MD.
    Hepatogastroenterology; 2004 Nov 15; 51(59):1544-7. PubMed ID: 15362797
    [Abstract] [Full Text] [Related]

  • 10. [Clinical significance of plasma fibrinogen level in patients with colorectal cancer].
    Wang Q, Xie R, Zhang QY.
    Zhonghua Zhong Liu Za Zhi; 2005 Sep 15; 27(9):544-6. PubMed ID: 16438853
    [Abstract] [Full Text] [Related]

  • 11. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
    Jiang XT, Tao HQ, Zou SC.
    Hepatobiliary Pancreat Dis Int; 2004 Aug 15; 3(3):464-8. PubMed ID: 15313690
    [Abstract] [Full Text] [Related]

  • 12. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D, Nürnberg R, Bahlo M, Klapdor R.
    Anticancer Res; 1999 Aug 15; 19(4A):2443-50. PubMed ID: 10470173
    [Abstract] [Full Text] [Related]

  • 13. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].
    Grotowski M, Maruszyński M, Piechota W.
    Pol Merkur Lekarski; 2001 Dec 15; 11(66):476-9. PubMed ID: 11899841
    [Abstract] [Full Text] [Related]

  • 14. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
    Liao Q, Zhao YP, Yang YC, Li LJ, Long X, Han SM.
    Hepatobiliary Pancreat Dis Int; 2007 Dec 15; 6(6):641-5. PubMed ID: 18086633
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of CA72-4 as a tumor marker in patients with gastric cancer].
    Ubukata H, Katano M, Motohashi G, Kasuga T, Takemura A, Tabuchi T, Tabuchi T.
    Gan To Kagaku Ryoho; 2003 Oct 15; 30(11):1821-4. PubMed ID: 14619529
    [Abstract] [Full Text] [Related]

  • 16. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
    Chen CC, Yang SH, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Chang SC.
    J Surg Res; 2005 Apr 15; 124(2):169-74. PubMed ID: 15820244
    [Abstract] [Full Text] [Related]

  • 17. [Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer].
    Zhu YB, Ge SH, Zhang LH, Wang XH, Xing XF, DU H, Hu Y, Li YA, Jia YN, Lin Y, Fan B, Ji JF.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb 15; 15(2):161-4. PubMed ID: 22368025
    [Abstract] [Full Text] [Related]

  • 18. A comparative analysis of the serum levels of NCC-ST-439, CEA and CA19-9 in patients with colorectal carcinoma.
    Iemura K, Moriya Y.
    Eur J Surg Oncol; 1993 Oct 15; 19(5):439-42. PubMed ID: 8405479
    [Abstract] [Full Text] [Related]

  • 19. CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.
    Engarås B, Kewenter J, Nilsson O, Wedel H, Hafström L.
    Eur J Surg Oncol; 2001 Feb 15; 27(1):43-8. PubMed ID: 11237491
    [Abstract] [Full Text] [Related]

  • 20. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.
    Sato T, Nishimura G, Nonomura A, Miwa K, Miyazaki I.
    Hepatogastroenterology; 1999 Feb 15; 46(26):914-9. PubMed ID: 10370638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.